Literature DB >> 11498288

Direct effect of Taxol on free radical formation and mitochondrial permeability transition.

G Varbiro1, B Veres, F Gallyas, B Sumegi.   

Abstract

To elucidate the potential role of mitochondria in Taxol-induced cytotoxicity, we studied its direct mitochondrial effects. In Percoll-gradient purified liver mitochondria, Taxol induced large amplitude swelling in a concentration-dependent manner in the microM range. Opening of the permeability pore was also confirmed by the access of mitochondrial matrix enzymes for membrane impermeable substrates in Taxol-treated mitochondria. Taxol induced the dissipation of mitochondrial membrane potential (DeltaPsi) determined by Rhodamine123 release and induced the release of cytochrome c from the intermembrane space. All these effects were inhibited by 2.5 microM cyclosporine A. Taxol significantly increased the formation of reactive oxygen species (ROS) in both the aqueous and the lipid phase as determined by dihydrorhodamine123 and resorufin derivative. Cytochrome oxidase inhibitor CN(-), azide, and NO abrogated the Taxol-induced mitochondrial ROS formation while inhibitors of the other respiratory complexes and cyclosporine A had no effect. We confirmed that the Taxol-induced collapse of DeltaPsi and the induction of ROS production occurs in BRL-3A cells. In conclusion, Taxol-induced adenine nucleotide translocase-cyclophilin complex mediated permeability transition, and cytochrome oxidase mediated ROS production. Because both cytochrome c release and mitochondrial ROS production can induce suicide pathways, the direct mitochondrial effects of Taxol may contribute to its cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498288     DOI: 10.1016/s0891-5849(01)00616-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  68 in total

Review 1.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

2.  Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy.

Authors:  Xuxian Xiao; Qiongqiong He; Kelong Huang
Journal:  Med Oncol       Date:  2009-12-01       Impact factor: 3.064

3.  Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

Authors:  Gamaleldin I Harisa; Mohamed F Ibrahim; Fars Alanazi; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2013-01-07       Impact factor: 4.330

Review 4.  Biological effects and medical applications of infrared radiation.

Authors:  Shang-Ru Tsai; Michael R Hamblin
Journal:  J Photochem Photobiol B       Date:  2017-04-13       Impact factor: 6.252

5.  Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis.

Authors:  Jian Wen; Syn Yeo; Chenran Wang; Song Chen; Shaogang Sun; Michael A Haas; Wei Tu; Feng Jin; Jun-Lin Guan
Journal:  Breast Cancer Res Treat       Date:  2015-02-01       Impact factor: 4.872

6.  The protective effect of α-Lipoic acid on mitochondria in the kidney of diabetic rats.

Authors:  Li Wang; Chen-Guang Wu; Chun-Qian Fang; Jing Gao; Ying-Zhao Liu; Yan Chen; Yu-Ning Chen; Zhi-Gang Xu
Journal:  Int J Clin Exp Med       Date:  2013-01-26

7.  Facilitation of mitochondrial outer and inner membrane permeabilization and cell death in oxidative stress by a novel Bcl-2 homology 3 domain protein.

Authors:  Andras Szigeti; Eniko Hocsak; Edit Rapolti; Boglarka Racz; Arpad Boronkai; Eva Pozsgai; Balazs Debreceni; Zita Bognar; Szabolcs Bellyei; Balazs Sumegi; Ferenc Gallyas
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

8.  Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.

Authors:  Tanja Hadzic; Nükhet Aykin-Burns; Yueming Zhu; Mitchell C Coleman; Katie Leick; Geraldine M Jacobson; Douglas R Spitz
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

9.  Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel.

Authors:  Wen Hua Xiao; Felix Y Zheng; Gary J Bennett; Thierry Bordet; Rebecca M Pruss
Journal:  Pain       Date:  2009-10-14       Impact factor: 6.961

10.  Transcriptional control of Flt3 ligand targeted by fluorouracil-induced Egr-1 promoter in hematopoietic damage.

Authors:  Nan Du; Xuetao Pei; Jinming Zhou; Hui Zhao; Xiaosong Li; Yan Fu; Yixin Hao
Journal:  J Biomed Sci       Date:  2009-09-21       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.